Point72 Asset Management »

Kyverna Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $519k 21k 24.84

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)
Broadcom (AVGO)
At&t (T)
Microsoft Corporation (MSFT)
Fox Corp Cl A Com (FOXA)
FedEx Corporation (FDX)
Arista Networks (ANET)
Coca-Cola Company (KO)
Paypal Holdings (PYPL)
Edwards Lifesciences (EW)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)

View all positions for Point72 Asset Management

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Millennium Management
Henderson Group
Adage Capital Partners GP
Citadel Advisors
Logos Global Management

View all funds holding Kyverna Therapeutics